Table 2:

The bactericidal effect of urine of patients treated with AM.

Pt No.	AM concentration (mg/L)	eGFR (mL/min/1.73 m2)	Antibiotic co-medication	Dilution with bacterial growth (E. coli)
Patients treated by dialysis
1	69	N/A	Vancomycin	1:2
	80	N/A		<1:2
2	0	N/A	No	<1:2
	176	N/A		<1:2
	142	N/A		<1:2
3	36	N/A	Vancomycin	1:2
	57	N/A		1:2
	75	N/A		1:2
	70	N/A		<1:2
4	69	N/A	Meropenem	1:64
	69	N/A		1:128
5	205	N/A	Ampicillin/sulbactam	1:32
	202	N/A		1:128
	78	N/A		1:128
	146	N/A		1:256
	234	N/A		1:256
	54	N/A		1:128
6	150	N/A	Piperacillin/tazobactam	1:512
	252	N/A		1:256
	248	N/A		>1:1024
7	68	N/A	Imipenem/cilastatin	1:4
	45	N/A		1:8
	34	N/A		1:4
8	108	N/A	Piperacillin/tazobactam	1:64
	98	N/A		1:32
	93	N/A		1:32
Patients not treated by dialysis
9	671	75	No	1:16
	173			1:8
	1073			1:16
	145			1:8
10	382	8	No	1:8
	225			1:16
	218			1:16
	120			1:8
11	3681	94	No	1:32
	1557			1:32
	878			1:16
	183			1:8
	205			1:8
12	768	75	Amoxicilin/clavulanate	1:16
	514			1:32
	1206			1:16
	116			1:8
13	846	46	Amoxicilin/clavulanate	1:16
	193			1:16
	150			1:16
	211			1:8
14	719	21	Metronidazole	1:8
	268			1:4
	126			1:4
	352			1:4
	183			1:4
15	1704	32	Ampicillin/sulbactam	1:64
	664			1:64
	1628			1:32